TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
CommunityDashboard
Log inCreate Account
← Back to TickerSpark
▌Research Report·July 31, 2026

Estee Lauder (EL): Recovery Story With Leverage Risk

Estee Lauder is showing early signs of a turnaround, with fragrance, online sales, and Mainland China improving. But heavy debt, negative earnings, and restructuring costs keep this a Hold.

Research ReportELConsumer DefensiveHousehold & Personal ProductsConsumer Staples
By TickerSpark·July 31, 2026·19 min read

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Estee Lauder (EL): Recovery Story With Leverage Risk
C+
Overall
C
Balance Sheet
C+
Income
B+
Estimates
C+
Valuation
TickerSpark AI RatingHold
▌Investment Summary
Estee Lauder Companies Inc. (EL) is a Hold, earning an overall grade of C+ as the recovery in fragrance, online channels, and Mainland China starts to offset a weak fiscal 2025. Our fair value is $95, and the stock looks investable for patient investors only if management can sustain margin recovery and reduce leverage.

Thesis

Estee Lauder Companies Inc. (EL) is a recovery investment, not a clean defensive compounder. The company owns a powerful portfolio of prestige brands, yet fiscal 2025 revenue fell to $14.29B, net income was negative $1.13B, and debt reached $7.72B against $2.92B of cash. The recovery case rests on a specific set of improving facts: fiscal third-quarter organic sales rose 2%, adjusted diluted EPS increased 40% to $0.91, operating margin reached 15%, and management raised fiscal 2026 guidance.

The strongest evidence is concentrated in fragrance, online channels, Mainland China, and U.S. prestige beauty. Fragrance delivered double-digit organic growth, online organic sales grew double digit in the quarter, Mainland China posted high single-digit retail sales growth, and EL gained U.S. volume share across all four categories. Management's preliminary fiscal 2027 plan calls for 3% to 5% organic sales growth and a 12.5% to 13% operating margin.

The counterweight is balance-sheet leverage and the uneven quality of the earnings recovery. TTM EPS remains negative at $0.70, net margin is negative 1.7%, debt-to-equity is 2.0, and the Profit Recovery and Growth Plan carries expected restructuring and other charges of $1.5B to $1.7B before taxes. A moderate-risk investor with a medium-term horizon has a defensible reason to own EL, but the evidence supports a Hold rather than an aggressive Buy.

Company Overview

EL manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. Founded in 1946 and headquartered in New York, the company employs about 40,470 people and sells through department stores, duty-free retailers, specialty multi-retailers, upscale perfumeries, pharmacies, salons, spas, company stores, brand websites, and third-party online platforms.

The portfolio spans more than 20 prestige brands, including Estee Lauder, Clinique, La Mer, M·A·C, Jo Malone London, Le Labo, TOM FORD Beauty, Aveda, The Ordinary, Dr.Jart+, Too Faced, Bobbi Brown Cosmetics, KILIAN PARIS, and Bumble and bumble. This breadth gives EL exposure to multiple price tiers and consumer occasions, but it also creates a complicated operating structure. Management's One ELC initiative is designed to reduce layers and silos across brands, regions, and functions.

▌Common Questions

Frequently asked questions

+Is EL stock a buy right now?
EL is not a Buy right now; it is a Hold because the recovery is real but still uneven. Fragrance, online sales, and Mainland China are improving, yet negative net income, $7.72B of debt, and restructuring charges keep the risk profile elevated.
+What is EL's fair value?
Estee Lauder's fair value is $95. We arrive at that by weighing the report's C+ overall grade, the improving estimates outlook, and the still-stretched balance sheet against a recovery in organic sales, margin expansion, and a valuation that remains constrained by negative TTM EPS.
+What are the biggest reasons to own Estee Lauder shares?
▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

Daily market recap + weekly preview. One-click unsubscribe in every email.

The investment story changed under CEO Stephane de la Faverie and the Beauty Reimagined strategy. Management is attempting to restore growth while simplifying the operating model, increasing consumer-facing investment, shifting distribution toward faster-growing channels, and rebuilding profitability. That is a sensible direction, but the transformation is expensive and execution-heavy.

Business Segment Deep Dive

Skin care is EL's largest category. Fiscal 2025 skin care revenue was $6.96B, or 48.9% of total segment revenue, down from $7.91B and 51.0% in fiscal 2024. La Mer, Estee Lauder skin care, Clinique, The Ordinary, and Dr.Jart+ provide exposure from luxury to accessible prestige.

Makeup generated $4.21B in fiscal 2025 revenue, or 29.6% of the portfolio. The category declined from $4.47B in fiscal 2024, but recent trends improved. Double Wear supported double-digit growth for the Estee Lauder makeup brand, while M·A·C gained traction after entering U.S. Sephora stores.

Fragrance produced $2.49B in fiscal 2025 revenue, or 17.5% of the portfolio. Its share of the mix increased from 16.1% in fiscal 2024 even as total revenue declined. Fragrance is currently the clearest growth engine, with double-digit organic growth across regions and strong performances from Le Labo, TOM FORD, KILIAN PARIS, and Jo Malone London.

Hair care is smaller at $565M, or 4.0% of fiscal 2025 segment revenue. Aveda and The Ordinary helped EL gain value share in U.S. prestige hair care, and management described hair care as stabilized. That is an improvement in direction, though the category remains too small to offset a major skin care or makeup setback.

Get AI research on any stock

Instant reports, daily intelligence, and an AI analyst in your pocket.

Get Started →

Flagship Product Analysis

La Mer remains one of EL's most important luxury assets. The new rejuvenating eye cream and related experiential campaign made La Mer the company's greatest contributor to organic sales growth in the quarter. Breakthrough La Mer eye launches also supported skin care performance in Mainland China.

Le Labo illustrates how EL can turn a niche luxury brand into a global growth platform. The brand posted strong double-digit organic sales growth and high single-digit like-for-like door growth, helped by Violette 30. TOM FORD added Figue Érotique after the successful Oud Voyager launch, while KILIAN PARIS used Her Majesty to deliver strong double-digit brand growth.

Double Wear is the most visible recent makeup example. The next-generation Matte foundation drove double-digit growth for the Estee Lauder makeup brand and received global activation aimed at consumer acquisition. M·A·C's Lip and cheek Mousse aligned with the multi-use makeup trend, and M·A·C ranked as the number one lead makeup brand in the Sephora stores where it launched during March.

The Ordinary provides a different type of flagship asset. Its dictionary-themed pop-up campaign ran across five countries, while the brand extended double-digit organic sales growth and gained U.S. skin care value share. The combination of accessible prestige pricing and digital reach gives The Ordinary a useful role in recruiting younger consumers.

Innovation & Competitive Advantage

EL's main competitive advantage is portfolio depth. La Mer and TOM FORD support luxury positioning, The Ordinary expands access, M·A·C and Clinique provide established makeup platforms, and Le Labo and KILIAN PARIS add fast-growing fragrance exposure. Few companies can combine this many recognizable names across skin care, makeup, fragrance, and hair care.

Recent innovation supports the advantage with concrete results. Management reported that fragrance newness resonated across every region, while skin care launches supported La Mer and the Estee Lauder Supreme franchise in Mainland China. EL also invested in Forest Essentials, the number one prestige skin care brand in India, and made a minority investment in 111Skin, a luxury skin care brand focused on pre- and post-procedure demand.

Digital distribution is becoming equally important. EL expanded Amazon Premium Beauty stores across 10 markets, added brands to TikTok Shop in the U.S., Germany, and Malaysia, and expanded its China presence on Douyin and vip.com. Strong performance on Douyin, Tmall, and Coupang drove double-digit online organic sales growth in the third quarter and 10% growth for the first nine months.

The moat has limits. McKinsey estimates that mass and masstige brands have gained five percentage points of global share in skin care and makeup over five years. EL therefore needs innovation and brand investment to justify premium prices, rather than relying on heritage alone.

Operations & Supply Chain

The Profit Recovery and Growth Plan is the operational center of the recovery. Through March 31, 2026, EL recorded $1.1B of cumulative restructuring charges, primarily related to employee costs. Management raised expected total restructuring and other charges to $1.5B to $1.7B before taxes after adding initiatives tied to channel and selling-model changes.

The plan is also producing measurable efficiency gains. Third-quarter gross margin reached 76.4%, up 140 basis points year over year. Management attributed the improvement to PRGP execution, zero-waste programs, lower excess and obsolescence costs, and improved sales leverage, partly offset by tariffs and inflation.

EL is moving away from selected unproductive department-store and freestanding-store doors while expanding online distribution. Accenture is helping consolidate enterprise services, Shopify is modernizing direct-to-consumer operations, and WPP is supporting unified media buying. Enterprise Business Services is scheduled for full deployment by the end of calendar 2026.

The supply-chain risk is visible in the cost structure. Management cited incremental tariffs, inflation, and Middle East disruption as active pressures. A $306M nine-month capital expenditure program, down 23% year over year, shows that EL is prioritizing consumer-facing investments while controlling other spending.

Market Analysis

The addressable market is large and expanding, but growth is becoming more selective. McKinsey estimates that core beauty categories will reach $590B by 2030 with about 5% annual growth over the next five years. Skin care is expected to represent 40% of market value, which aligns with EL's largest category exposure.

Digital commerce is reshaping the route to market. McKinsey expects global beauty e-commerce penetration to exceed 30% by 2030. EL's 10% online organic growth for the first nine months and new placements on Amazon, TikTok Shop, Douyin, Tmall, and Coupang show that the company is adapting to this shift.

Fragrance is the most favorable part of the market for EL at present. The category generated double-digit organic growth across regions, while the company's management cited luxury fragrance brands as the leading contributors. Skin care remains the largest opportunity, but the third-quarter transcript also acknowledged that global skin care had less product newness than the prior-year quarter.

Like what you're reading?

Get full access to AI-powered research reports, market analysis, and portfolio tools.

Get Started →

Customer Profile

EL serves consumers who purchase prestige skin care, makeup, fragrance, and hair care through a mix of physical and digital channels. The portfolio reaches luxury shoppers through La Mer, Le Labo, and TOM FORD, while The Ordinary, Clinique, M·A·C, and Aveda broaden the addressable consumer base.

The company is targeting younger and digitally engaged consumers. Management said consumers are entering beauty at younger ages and staying in the category longer. The Ordinary's digital growth, M·A·C's Sephora launch, and TikTok Shop expansion are direct responses to that behavior.

Customer acquisition is becoming more expensive and more dependent on paid media. Gartner reports that personal-care marketers are relying more heavily on paid media as organic website traffic declines. That increases the value of EL's brand recognition, but it also raises the cost of maintaining relevance across many brands and markets.

Competitive Landscape

EL competes with L'Oréal, Unilever, Procter & Gamble, LVMH, Chanel, Beiersdorf, Shiseido, Coty, Puig, retailer-owned brands, and independent digital-native labels. L'Oréal reported €44.05B of revenue in 2025, demonstrating the scale advantage of the largest global beauty competitor.

Coty is a useful category reference because it generated $5.89B of fiscal 2025 revenue, with 65% from prestige. Its concentration in prestige fragrance places it closer to EL's strongest current category than mass-market competitors such as Unilever or Procter & Gamble.

EL's advantage is brand variety and luxury credibility. Its weakness is execution complexity, particularly in China, travel retail, department stores, and wholesale relationships. Management's reported share gains in Mainland China, the U.S., Japan, and Korea show progress, but competitors with greater scale or faster digital cycles can still pressure shelf space and consumer attention.

Macro & Geopolitical Landscape

China is the central macro swing factor. EL reported high single-digit Mainland China retail sales growth and five consecutive quarters of market-share gains. Travel retail in Hainan also improved sequentially, while Northern Asian travel retail and duty-free channel changes remained sources of pressure.

The Middle East conflict has a quantified effect on the outlook. Management expects approximately a 2 percentage point sales-growth impact and a $0.06 EPS impact in the fiscal fourth quarter. The full-year outlook includes less than a 1 percentage point sales impact and a $0.07 EPS impact.

Tariffs and inflation are direct margin risks. Management said third-quarter efficiency benefits offset incremental tariffs and inflation, while the February fiscal 2026 outlook included an estimated $100M unfavorable profitability impact from tariffs. Foreign exchange remains material as well: EL reported that a hypothetical 10% weakening of the U.S. dollar would have changed the fair value of its foreign-exchange portfolio by about $137M as of Dec. 31, 2025.

Regulation adds operating cost. The U.S. Modernization of Cosmetics Regulation Act requires facility registration and product listings, while European Commission Regulation 2026/909 changed allowed uses for multiple substances on Apr. 27, 2026. EL's scale helps it manage compliance, but multinational reformulation and labeling work can still weigh on margins.

Balance Sheet Health

▌Premium Members Only

Debt rose to $7.72B against $2.92B of cash, leaving Estee Lauder with a leveraged balance sheet that still needs meaningful repair.

Unlock the full analysis

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →

Income Statement Strength

▌Premium Members Only

Fiscal 2025 revenue fell to $14.29B and net income was negative $1.13B, even though fiscal third-quarter adjusted EPS jumped 40% to $0.91.

Unlock the full analysis

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →

Estimates Outlook

▌Premium Members Only

Management now expects fiscal 2027 organic sales growth of 3% to 5% and an operating margin of 12.5% to 13%, signaling a more durable recovery path.

Unlock the full analysis

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →

Valuation Assessment

▌Premium Members Only

With TTM EPS still negative at $0.70 and net margin at -1.7%, the valuation case depends more on a margin rebound than on current earnings power.

Unlock the full analysis

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →

Target Prices & Recommendation

▌Premium Members Only

The report’s fair value is $95, which supports a Hold while the recovery in fragrance, China, and online sales continues to prove itself.

Unlock the full analysis

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →

Closing

EL has moved from a deterioration story toward an execution story. The evidence is tangible: third-quarter organic sales growth returned, fragrance delivered double-digit growth, Mainland China gained share for a fifth consecutive quarter, online sales grew 10% year to date, and operating margin expanded sharply.

The balance sheet and trailing earnings prevent a stronger rating. Debt-to-equity is 2.0, fiscal 2025 net income was negative $1.13B, and the restructuring program carries $1.5B to $1.7B of expected charges before taxes. These risks are manageable only if the reported sales and margin improvements continue.

For a medium-term, moderate-risk portfolio, Hold is the disciplined conclusion. EL has credible brands, improving categories, and a clear operating plan, but the shares already reflect a meaningful portion of the recovery. The strongest risk-reward appears at $78 or below, while $95.00 remains the report's fair value estimate until earnings quality and leverage improve together.

The strongest positives are fragrance momentum, double-digit online organic growth, and improving demand in Mainland China. The company also gained U.S. volume share across all four categories, which suggests the brand portfolio still has meaningful pricing and distribution power.
+What is the main risk for EL investors?
The main risk is that the turnaround takes longer than expected while leverage stays high. Debt of $7.72B versus $2.92B of cash, negative TTM EPS of $0.70, and $1.5B to $1.7B of restructuring and other charges all limit near-term upside.
+Which business areas are driving the recovery?
Fragrance is the clearest growth engine, with double-digit organic growth led by Le Labo, TOM FORD, KILIAN PARIS, and Jo Malone London. La Mer also helped drive organic sales growth, while online channels and U.S. prestige beauty share gains added further support.
▌For Active Investors

Want Reports Like This on Any Stock?

Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.

Get Full Access →

Not ready to subscribe? ·

▌For Active Investors

Stock research for every investor

  • Reports on any stock
  • Daily market intelligence
  • AI analyst in your pocket
  • Portfolio analysis tools
Get Full Access →

Cancel anytime

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌More on EL

More to read

All articles
Estée Lauder doesn’t need a deal if the turnaround is finally real
EL

Estée Lauder doesn’t need a deal if the turnaround is finally real

Estée Lauder's failed Puig talks look like a positive, not a setback. With M&A noise gone, the market can focus on a turnaround that is finally showing up in margins, China trends, and repeated earnings beats.

May 22·4 min
The Estée Lauder Companies Inc. (EL) climbs 11.7% after talks end
EL

The Estée Lauder Companies Inc. (EL) climbs 11.7% after talks end

The Estée Lauder Companies Inc. (EL) climbs sharply after hours after ending merger talks with Puig, removing a major uncertainty from the stock. The move is backed by stronger recent earnings, improved margins, and rising analyst targets, shifting focus back to EL’s standalone turnaround story.

May 22·6 min
The Estée Lauder Companies Inc. (EL) climbs as Puig talks end
EL

The Estée Lauder Companies Inc. (EL) climbs as Puig talks end

The Estée Lauder Companies Inc. (EL) climbs after-hours after ending merger talks with Puig, removing deal uncertainty and refocusing attention on its turnaround. Investors are also reacting to stronger recent earnings, raised profit guidance, and deeper cost cuts that support a simpler recovery story.

May 21·6 min